RECORDATI: ISTURISA® (OSILODROSTAT) PHASE III LINC-4 TRIAL MEETS ITS PRIMARY ENDPOINT IN CUSHING’S DISEASE 06/17/2020 RECORDATI RARE DISEASES INC. ANNOUNCES AVAILABILITY OF ISTURISA® (OSILODROSTAT) IN THE UNITED STATES 05/27/2020 RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED IN THE U.S. 03/09/2020 Pagination First page « First Previous page ‹ Previous … Page 9 Current page 10 Page 11 Page 12 … Next page Next › Last page Last »
RECORDATI: ISTURISA® (OSILODROSTAT) PHASE III LINC-4 TRIAL MEETS ITS PRIMARY ENDPOINT IN CUSHING’S DISEASE 06/17/2020
RECORDATI RARE DISEASES INC. ANNOUNCES AVAILABILITY OF ISTURISA® (OSILODROSTAT) IN THE UNITED STATES 05/27/2020
